Abstract
Culturing of mesenchymal stem cells (MSCs) for different cell therapies requires advancements to enable routine application in clinical environments. The primary concern pertains to the utilization of reagents derived from animals, particularly the incorporation of fetal bovine serum (FBS) into the culture medium. The human platelet lysate (HPL) has emerged as an excellent supplement for a viable animal-free alternative and MSC culture. Most of the researchers focused on the proliferation rates of cells grown with FBS and HPL. Moreover, the HPL was able to enhance the secretion of vascular endothelial growth factor and maintain the immunomodulatory function of various cell types. This mini-review presents novel contributions from recent papers, highlighting the superior efficacy of HPL over FBS, which may facilitate the scientific community's shift towards cellular growth for various clinical applications.
References
Zhao Q, Han Z, Wang J, Han Z. Development and investigational new drug application of mesenchymal stem/stromal cells products in China. Stem cells translational medicine. 2021;10:S18-S30.
Lee SY, Yun SH, Jeong JW, Kim JH, Kim HW, Choi JS, et al. Review of the current research on fetal bovine serum and the development of cultured meat. Food science of animal resources. 2022;42(5):775.
Guiotto M, Raffoul W, Hart A, Riehle M, Di Summa P. Human platelet lysate to substitute fetal bovine serum in hMSC expansion for translational applications: a systematic review. Journal of translational medicine. 2020;18(1):351.
Mareschi K, Marini E, Niclot AGSB, Barone M, Pinnetta G, Adamini A, et al. A new human platelet lysate for mesenchymal stem cell production compliant with good manufacturing practice conditions. International Journal of Molecular Sciences. 2022;23(6):3234.
Khongjaroensakun N, Paisooksantivatana K, Santiwatana S, Tawonsawatruk T, Kusolthammarat K, Kadegasem P, et al. A simple and applicable method for human platelet lysate preparation using citrate blood. Laboratory Medicine. 2022;53(5):e109-e112.
da Fonseca L, Santos GS, Huber SC, Setti TM, Setti T, Lana JF. Human platelet lysate–A potent (and overlooked) orthobiologic. Journal of clinical orthopaedics and trauma. 2021;21:101534.
Sun Z, Fukui M, Taketani S, Kako A, Kunieda S, Kakudo N. Predominant control of PDGF/PDGF receptor signaling in the migration and proliferation of human adipose‑derived stem cells under culture conditions with a combination of growth factors. Experimental and Therapeutic Medicine. 2024;27(4):156.
Zhao H, Li M, Ouyang Q, Lin G, Hu L. VEGF promotes endothelial cell differentiation from human embryonic stem cells mainly through PKC-ɛ/η pathway. Stem Cells and Development. 2020;29(2):90-99.
Wang M-K, Sun H-Q, Xiang Y-C, Jiang F, Su Y-P, Zou Z-M. Different roles of TGF-β in the multi-lineage differentiation of stem cells. World journal of stem cells. 2012;4(5):28.
Liu S, Ren J, Hu Y, Zhou F, Zhang L. TGFβ family signaling in human stem cell self-renewal and differentiation. Cell Regeneration. 2024;13(1):26.
Yan L, Zhou L, Yan B, Zhang L, Du W, Liu F, et al. Growth factors-based beneficial effects of platelet lysate on umbilical cord-derived stem cells and their synergistic use in osteoarthritis treatment. Cell death & disease. 2020;11(10):857.
Lei T, Liu Y, Deng S, Xiao Z, Yang Y, Zhang X, et al. Hydrogel supplemented with human platelet lysate enhances multi-lineage differentiation of mesenchymal stem cells. Journal of Nanobiotechnology. 2022;20(1):176.
Rashid U, Saba E, Yousaf A, Tareen WA, Sarfraz A, Rhee MH, et al. Autologous platelet lysate is an alternative to fetal bovine serum for canine adipose-derived mesenchymal stem cell culture and differentiation. Animals. 2023;13(16):2655.
Arutyunyan I, Elchaninov A, Makarov A, Fatkhudinov T. Umbilical cord as prospective source for mesenchymal stem cell‐based therapy. Stem cells international. 2016;2016(1):6901286.
Attaelmanan GA, Khalil HB. Assessment of Umbilical Cord Mesenchymal Stem Cell Cultivation Using Fetal Bovine Serum or Platelet Lysate. Cureus. 2025;17(1):e78044.
Kamaruddin MR, Baharuddin BZ, Ratha Manaalan N, Wong YL, Hassan MNF, Abdul Aziz S, et al. Effect of Different Forms of Human Platelet Lysate on the Proliferation and Phenotype of Human Osteoblasts. Applied Sciences. 2025;15(4):2074.
Duarte Rojas JM, Restrepo Múnera LM, Estrada Mira S. Evaluation of Platelet Lysate-Based Medium and Protein Substrate for HUVEC Culture and Expansion. Biomedicines. 2025;13(5):1187.
Wendland K, Koblin L, Stobbe D, Dahms A, Singer D, Bekeschus S, et al. Lyophilized human platelet lysate: manufacturing, quality control, and application. Frontiers in Cell and Developmental Biology. 2025;13:1513444.
Lim YT, Barathan M, Tan YL, Lee YT, Law JX. Calcium Chloride vs. mechanical preparation of fibrinogen-depleted human platelet lysate: implications for umbilical cord mesenchymal stem cell culture. Life. 2024;15(1):12.
Ho WF, Wan CC, Chan KW, Hui P. Human platelet transfusion: a narrative review. Annals of Blood. 2025;10.
Yeh HC, Gupta K, Lu Y-H, Srinivasan A, Delila L, Yen NTH, et al. Platelet Extracellular Vesicles as Natural Delivery Vehicles for Mitochondrial Dysfunction Therapy? ACS Biomaterials Science & Engineering. 2025;11(5):2601-2621.
Lin Y, Lin H, Huang M, Liu K. Advancing the Development of Innovative Human Platelet-Derived Exosomes for Enhanced Therapeutic Applications. Cytotherapy. 2025;27(5):S85.
Wakamoto S, Furukawa T, Kawabori M, Akino M, Kato S, Fuse H, et al. Human platelet lysate produced from leukoreduction filter contents enables sufficient MSC growth. Stem Cell Research & Therapy. 2025;16(1):205.
Zhang H, Li D, Zheng W, Hua J, Chen Z, Xu W, et al. Enhancing Cartilage Repair in Osteoarthritis Using Platelet Lysates and Arthroscopic Microfracture. Drug Design, Development and Therapy. 2025:3827-3843.
This work is licensed under a Creative Commons Attribution 4.0 International License.
Copyright (c) 2025 Mansur Abdullah Sandhu, Evelyn Saba (Author)